BASP1 and Alzheimer disease: Notably, recent studies have shown that levels of BASP1 are decreased in AD patients (Musunuri et al., 2014), and the protein often demonstrates decreased phosphorylation in the temporal lobes compared to non-AD subjects (Tagawa et al., 2015).